A meta-analysis involving 28 studies with 19,348 participants indicated that a high serum FGF21 level may predict the incidence of chronic kidney disease (CKD) and renal outcomes in patients with T2DM (72). This evidence concerns the gene FGF21 and type 2 diabetes mellitus.